title: Magnetic nanoformulation of azidothymidine 5'-triphosphate for targeted delivery across the blood-brain barrier.
abstract: Despite significant advances in highly active antiretroviral therapy (HAART), the prevalence of neuroAIDS remains high. This is mainly attributed to inability of antiretroviral therapy (ART) to cross the blood-brain barrier (BBB), thus resulting in insufficient drug concentration within the brain. Therefore, development of an active drug targeting system is an attractive strategy to increase the efficacy and delivery of ART to the brain. We report herein development of magnetic azidothymidine 5'-triphosphate (AZTTP) liposomal nanoformulation and its ability to transmigrate across an in vitro BBB model by application of an external magnetic field. We hypothesize that this magnetically guided nanoformulation can transverse the BBB by direct transport or via monocyte-mediated transport. Magnetic AZTTP liposomes were prepared using a mixture of phosphatidyl choline and cholesterol. The average size of prepared liposomes was about 150 nm with maximum drug and magnetite loading efficiency of 54.5% and 45.3%, respectively. Further, magnetic AZTTP liposomes were checked for transmigration across an in vitro BBB model using direct or monocyte-mediated transport by application of an external magnetic field. The results show that apparent permeability of magnetic AZTTP liposomes was 3-fold higher than free AZTTP. Also, the magnetic AZTTP liposomes were efficiently taken up by monocytes and these magnetic monocytes showed enhanced transendothelial migration compared to normal/non-magnetic monocytes in presence of an external magnetic field. Thus, we anticipate that the developed magnetic nanoformulation can be used for targeting active nucleotide analog reverse transcriptase inhibitors to the brain by application of an external magnetic force and thereby eliminate the brain HIV reservoir and help to treat neuroAIDS.
authors.affiliation: Department of Immunology, College of Medicine, Florida International University, Miami, FL, USA.
authors.forename: Zainulabedin M
authors.initials: ZM
authors.lastname: Saiyed
authors.forename: Nimisha H
authors.initials: NH
authors.lastname: Gandhi
authors.forename: Madhavan P N
authors.initials: MP
authors.lastname: Nair
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage / Q000737:chemistry; D001812:Blood-Brain Barrier / Q000737:chemistry*; D002478:Cells, Cultured; D054306:Dideoxynucleotides / Q000008:administration & dosage* / Q000737:chemistry*; D004058:Diffusion; D004337:Drug Carriers / Q000008:administration & dosage / Q000737:chemistry*; D004339:Drug Compounding / Q000379:methods; D004574:Electromagnetic Fields; D006801:Humans; D008422:Materials Testing; D050997:Nanomedicine / Q000379:methods; D049329:Nanostructures / Q000008:administration & dosage / Q000737:chemistry*; D013942:Thymine Nucleotides / Q000008:administration & dosage* / Q000737:chemistry*; D015215:Zidovudine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000737:chemistry
chemical_list: D000998:Antiviral Agents; D054306:Dideoxynucleotides; D004337:Drug Carriers; D013942:Thymine Nucleotides; D015215:Zidovudine; C052873:zidovudine triphosphate
references.citation: Mol Med Today. 1997 Aug;3(8):335-41
references.pmid: 9269686
references.citation: Radiology. 2007 Aug;244(2):439-48
references.pmid: 17562813
references.citation: Int J Oncol. 2000 Aug;17(2):309-15
references.pmid: 10891540
references.citation: J Immunol. 2009 Jul 1;183(1):661-9
references.pmid: 19535632
references.citation: J Transl Med. 2009 Sep 01;7:77
references.pmid: 19723323
references.citation: J Control Release. 2008 Dec 8;132(2):84-90
references.pmid: 18805446
references.citation: Bioconjug Chem. 2007 Sep-Oct;18(5):1498-506
references.pmid: 17760417
references.citation: Surg Neurol. 2007 Feb;67(2):113-6
references.pmid: 17254859
references.citation: AIDS Res Hum Retroviruses. 1990 May;6(5):691-702
references.pmid: 2163269
references.citation: Nature. 1990 Jan 4;343(6253):85-9
references.pmid: 2296295
references.citation: Expert Opin Drug Deliv. 2007 Jan;4(1):5-17
references.pmid: 17184158
references.citation: Nat Rev Drug Discov. 2004 Jun;3(6):499-508
references.pmid: 15173839
references.citation: Anal Biochem. 1980 May 1;104(1):10-4
references.pmid: 6892980
references.citation: Nanomedicine (Lond). 2009 Jul;4(5):557-74
references.pmid: 19572821
references.citation: Blood. 2006 Oct 15;108(8):2827-35
references.pmid: 16809617
references.citation: J Leukoc Biol. 2005 Dec;78(6):1223-32
references.pmid: 16204625
references.citation: Blood. 1992 Mar 1;79(5):1137-43
references.pmid: 1371411
references.citation: Mol Pharm. 2005 Nov-Dec;2(6):449-61
references.pmid: 16323952
references.citation: AIDS Res Hum Retroviruses. 1994 Sep;10(9):1179-86
references.pmid: 7826702
references.citation: Biomaterials. 2008 Feb;29(4):487-96
references.pmid: 17964647
references.citation: Eur J Neurosci. 2003 Nov;18(9):2538-44
references.pmid: 14622154
references.citation: J Chromatogr. 1992 Aug 7;579(1):107-14
references.pmid: 1447336
references.citation: J Neuroimmune Pharmacol. 2007 Mar;2(1):105-11
references.pmid: 18040833
references.citation: AIDS Res Hum Retroviruses. 2009 Jul;25(7):691-9
references.pmid: 19621989
references.citation: Med Sci (Paris). 2004 Oct;20(10):882-6
references.pmid: 15461965
references.citation: J Biosci Bioeng. 2005 Jul;100(1):1-11
references.pmid: 16233845
references.citation: AIDS. 2008 Aug 20;22(13):1539-49
references.pmid: 18670212
references.citation: J Immunol. 1997 Apr 1;158(7):3499-510
references.pmid: 9120312
references.citation: J Control Release. 2007 Aug 16;121(1-2):19-27
references.pmid: 17509713
references.citation: J Occup Med Toxicol. 2007 Dec 01;2:16
references.pmid: 18053152
references.citation: Int J Pharm. 2003 Aug 11;261(1-2):43-55
references.pmid: 12878394
references.citation: Gene Ther. 2008 Jun;15(12):902-10
references.pmid: 18418420
references.citation: N Engl J Med. 1995 Apr 6;332(14):934-40
references.pmid: 7877652
references.citation: Biomagn Res Technol. 2003 Sep 18;1(1):2
references.pmid: 14521720
references.citation: Annu Rev Microbiol. 1992;46:655-93
references.pmid: 1444270
references.citation: AIDS Res Hum Retroviruses. 1996 Feb 10;12(3):223-8
references.pmid: 8835200
references.citation: J Neurovirol. 2009 Jul;15(4):343-7
references.pmid: 19575326
references.citation: J Acquir Immune Defic Syndr. 2006 Jan 1;41(1):23-30
references.pmid: 16340469